方法学

PARP-CD38 驱动的 NAD+ 流失与免疫衰老:新兴机制框架

来源:Aging and disease · PMID 42970312 · DOI 10.14336/AD.2026.0890 · 来源:IMA 知识库《文献层·文献监控卡片》2026-11-05 期 · 全文级(file_id dAlZBwueyWSz,实际下载核验 1,395,640 B) · 全文已获取并通过三重归属校验

时间标签:数据日期 2026-11-05 · 生成时间 2026-11-05 05:30(Asia/Shanghai)| 检索窗口 PubMed edat 2026/11/02 – 2026/11/06 | 情报发生日期 2026-11-05

研究问题

Unresolved questions, whether PBMC PARP activity predicts immune aging, sex differences, and whether partial inhibition reduces NAD+ consumption without compromising DNA repair.

方法

We propose a context-dependent PARP-CD38-NAD+-inflammaging hierarchy.;By rethinking PARPs as context-dependent integrators, we provide a framework for immunogerontology.;PARP3 restrains Lgr5+ intestinal stem cell proliferation in mice, and organoid models contribute to intestinal aging [30].

核心结论

In vitro studies demonstrate that PARP1 rapidly consumes NAD+ upon DNA damage activation, with the capacity to deplete cellular NAD+ pools under acute stress conditions [10, 20, 28].;These findings suggest that NAD+ decline may be tissue-specific and compartment-specific rather than a universal feature of aging and that blood NAD+ is not a reliable biomarker in geroscience [23].

局限

However, research from 2020 to 2026 has shown that PARPs operate beyond the nucleus, regulating nuclear factor kB (NF-κB) signaling, inflammasome activation, type-I interferon responses, and macrophage polarization through both catalytic and non-catalytic mechanisms [8, 9].;However, recent evidence challenges the universal NAD+ decline, with direct human data from skeletal muscle and whole blood showing that NAD+ levels may not decline uniformly with age [22, 23].;However, recent research has revealed the immunomodulatory functions of PARP1 in T-cells and macrophages, particularly in cytokine expression and regulation of cyclic GMP-AMP synthase and stimulator of interferon genes (cGAS-STING) pathways [8, 27].

对本项目的价值

中高价值:属「衰老细胞清除 / SASP 轴」方向;细胞衰老 / senolytics / SASP栏目可用作本项目文献库与综述素材。 | 价值分 3.0/5(★★★☆☆)

全文来源

出版商/仓储 OA PDF(正文 18,652 字符,题名指纹 1.0,正文内 DOI 命中,已过题名指纹 + 正文长度归属校验)

原文题录

  • 中文题名:PARP-CD38 驱动的 NAD+ 流失与免疫衰老:新兴机制框架
  • 英文标题:PARP-CD38-Driven NAD(+) Loss in Immune Aging: An Emerging Mechanistic Framework.
  • 期刊与标识:Aging and disease · PMID 42970312 · DOI 10.14336/AD.2026.0890

C 级证据分级:C 级(预印本 / 观点评论,非原始研究)

本文属观点/评论类文献,不是原始研究。其论点依赖于作者对既有证据的梳理与判断,不构成新的实验证据。本站标注 C 级即为此意——阅读时请把它当作「领域内的思考框架」,而非「研究发现」。

关于本文的文献来源:本站依据 IMA 知识库「五刊监控·深度文献卡片」撰写,依据已获取的期刊全文(方法、样本量与结论已回到原文核对);未能获取全文的同批条目另行标注「摘要级」,全程未做任何数值推算补全。